Patents by Inventor Jae-Seob Kim

Jae-Seob Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8426570
    Abstract: The present invention relates to a recombinant expression vector for an animal cell containing a dihydrofolate reductase (DHFR) coding nucleotide sequence operatively linked to a DHFR promoter, to an animal cell line transformed by the vector, and to a method for preparing a target protein using the same. As compared with existing animal cell expression vectors, the vector of the present invention enables an effective screening of a cell line clone in which foreign genes are amplified together with DHFR genes even at a much lower methotrexate concentration. The present invention exhibits excellent effects in cell line preparation as high-productivity cell lines can be ensured in a short time through the use of a lower concentration of methotrexate in the process of protein production cell line establishment.
    Type: Grant
    Filed: July 7, 2009
    Date of Patent: April 23, 2013
    Assignee: Aprogen Inc.
    Inventors: Keun Soo Kim, Hye Kyung Ju, Choon Ju Jeon, Jae Seob Kim
  • Publication number: 20110117643
    Abstract: The present invention relates to a recombinant expression vector for an animal cell containing a dihydrofolate reductase (DHFR) coding nucleotide sequence operatively linked to a DHFR promoter, to an animal cell line transformed by the vector, and to a method for preparing a target protein using the same. As compared with existing animal cell expression vectors, the vector of the present invention enables an effective screening of a cell line clone in which foreign genes are amplified together with DHFR genes even at a much lower methotrexate concentration. The present invention exhibits excellent effects in cell line preparation as high-productivity cell lines can be ensured in a short time through the use of a lower concentration of methotrexate in the process of protein production cell line establishment.
    Type: Application
    Filed: July 7, 2009
    Publication date: May 19, 2011
    Applicant: Aprogen Inc.
    Inventors: Keun Soo Kim, Hye Kyung Ju, Choon Ju Jeon, Jae Seob Kim
  • Patent number: 6038210
    Abstract: A switchover device switches over a double module between first and second modules manually or automatically, in which the control signals and switchover signals are generated with of the logic combination circuits and relays, to simplify signal processing of the system.
    Type: Grant
    Filed: April 21, 1997
    Date of Patent: March 14, 2000
    Assignee: SamSung Electronics Co., Ltd.
    Inventor: Jae-Seob Kim